BMO Capital lowered its price target on aTyr Pharma (NASDAQ: LIFE) to $2.00 (from $4.00) while maintaining a Market Perform ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE